Literature DB >> 3032599

Quantitation of silica-induced type II cell hyperplasia by using alkaline phosphatase histochemistry in glycol methacrylate embedded lung.

B E Miller, R E Chapin, K E Pinkerton, L B Gilmore, R R Maronpot, G E Hook.   

Abstract

A light microscopic technique based on alkaline phosphatase histochemistry was developed to specifically quantitate Type II cells in the intact rat lung. Lungs were fixed in 4% neutral-buffered formalin containing 0.25 M sucrose and embedded in glycol methacrylate. Two micron thick sections were mounted on glass microscope slides. Alkaline phosphatase activity was localized by using naphthol AS-BI phosphate as substrate in 0.125 M 2-amino-2-methyl-1-propanol buffer containing 0.625 mM MgCl2 (pH 8.9). Sections were counterstained with Harris hematoxylin. Type II cells were the only cell type in the alveolar region containing alkaline phosphatase activity, an observation that was confirmed by using electron microscopic histochemistry. By combining the alkaline phosphatase staining technique with standard morphometric procedures, the proliferative response to a single intratracheal dose of 10 mg silica was followed as a function of time. Type II cells were significantly increased at all time points examined. Twenty eight days following silica, Type II cells had increased to (252 +/- 16) X 10(6) cells per set of lungs compared to a control value of (141 +/- 32) X 16(6) cells. The method presented is a simple and rapid technique for examining Type II cell population kinetics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032599     DOI: 10.3109/01902148709062837

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  11 in total

1.  Modulation of alkaline phosphatase activity in alveolar type II like cells.

Authors:  M Kalina; D Levi; S Riklis
Journal:  Histochemistry       Date:  1990

2.  A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells.

Authors:  A C Cunningham; J G Zhang; J V Moy; S Ali; J A Kirby
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

3.  Primary human alveolar epithelial cells can elicit the transendothelial migration of CD14+ monocytes and CD3+ lymphocytes.

Authors:  M Eghtesad; H E Jackson; A C Cunningham
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

4.  Stimulation of surfactant phospholipid biosynthesis in the lungs of rats treated with silica.

Authors:  B E Miller; G E Hook
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

5.  Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium.

Authors:  R J Panos; J S Rubin; K G Csaky; S A Aaronson; R J Mason
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Regulation and function of adhesion molecule expression by human alveolar epithelial cells.

Authors:  A C Cunningham; J A Kirby
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

7.  CCAAT/enhancer-binding protein γ is a critical regulator of IL-1β-induced IL-6 production in alveolar epithelial cells.

Authors:  Chunguang Yan; Ximo Wang; Jay Cao; Min Wu; Hongwei Gao
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 8.  Hypertrophy and hyperplasia of alveolar type II cells in response to silica and other pulmonary toxicants.

Authors:  B E Miller; G E Hook
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

9.  Type II pneumocytes in mixed cell culture of human lung: a light and electron microscopic study.

Authors:  L Bingle; T B Bull; B Fox; A Guz; R J Richards; T D Tetley
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

10.  Susceptibility of lung epithelium to neutrophil elastase: protection by native inhibitors.

Authors:  L Bingle; R J Richards; B Fox; L Masek; A Guz; T D Tetley
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.